Hydrocortison Al

Hydrocortison Al is a topical dermatological preparation that contains the corticosteroid hydrocortisone as its active ingredient. It is supplied without a specified brand name, strength, or dosage form, and is marketed within the European Union. The product is intended for external application to the skin, where it exerts anti‑inflammatory and immunosuppressive actions typical of glucocorticoids. It is classified under ATC code D07AA02 and used by healthcare professionals.

Hydrocortison Al is employed to manage a variety of inflammatory skin conditions where topical glucocorticoid therapy is appropriate, providing relief from redness, itching, and swelling. It is typically applied to the affected area once or twice daily, following the guidance of a healthcare professional. - Mild to moderate atopic dermatitis (eczema) - Contact dermatitis caused by allergens or irritants - Plaque psoriasis with limited surface involvement - Localized allergic skin reactions such as hives or insect bites - Minor inflammatory dermatoses including seborrheic dermatitis - Localized eczema flare‑ups

Topical hydrocortisone can cause local and, less frequently, systemic adverse reactions.

Common: - Mild skin irritation or burning sensation at the application site - Transient itching or dryness - Slight erythema or folliculitis - Minor acneiform eruptions

Serious: - Contact dermatitis or allergic reaction to the formulation - Skin atrophy or thinning with prolonged use - Secondary bacterial, fungal, or viral infection of the treated area

Before using Hydrocortison Al, certain precautions should be observed to minimize risks and ensure appropriate therapy. - Avoid application on broken, infected, or ulcerated skin unless directed by a clinician. - Do not use on large body surface areas or for prolonged periods without medical supervision. - Limit use on thin skin (e.g., face, genitalia, intertriginous zones) to reduce risk of atrophy. - Discontinue if signs of hypersensitivity such as rash, swelling, or severe burning develop. - Pregnant or breastfeeding individuals should consult a healthcare provider before use. - Children may be more susceptible to systemic absorption; use the lowest effective potency.

Hydrocortison Al may interact with other topical agents or systemic medications that affect skin integrity or glucocorticoid metabolism.

Avoid: - Concurrent use of other potent topical corticosteroids on the same area. - Application of occlusive dressings that increase drug absorption unless specifically advised. - Combination with topical antibiotics or antifungals that are not indicated for the same condition.

Use with caution: - Systemic corticosteroids, as additive immunosuppression may increase infection risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically near the treated site. - Antiviral or immunomodulatory therapies that could alter wound healing.